First Time Loading...

Oncolytics Biotech Inc
TSX:ONC

Watchlist Manager
Oncolytics Biotech Inc Logo
Oncolytics Biotech Inc
TSX:ONC
Watchlist
Price: 1.61 CAD -0.62% Market Closed
Updated: May 8, 2024

Wall Street
Price Targets

ONC Price Targets Summary
Oncolytics Biotech Inc

Wall Street analysts forecast ONC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ONC is 6.8 CAD with a low forecast of 3.03 CAD and a high forecast of 9.45 CAD.

Lowest
Price Target
3.03 CAD
88% Upside
Average
Price Target
6.8 CAD
322% Upside
Highest
Price Target
9.45 CAD
487% Upside
Oncolytics Biotech Inc Competitors:
Price Targets
GLPG
Galapagos NV
47% Upside
086900
Medy Tox Inc
72% Upside
IOVA
Iovance Biotherapeutics Inc
98% Upside
KRRO
Korro Bio Inc
146% Upside
KRTX
Karuna Therapeutics Inc
2% Downside
300841
Chengdu Kanghua Biological Products Co Ltd
33% Upside
VICO
Vicore Pharma Holding AB
187% Upside
IRWD
Ironwood Pharmaceuticals Inc
126% Upside

Revenue
Forecast

Revenue Estimate
Oncolytics Biotech Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Oncolytics Biotech Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Oncolytics Biotech Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-79%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ONC's stock price target?
Price Target
6.8 CAD

According to Wall Street analysts, the average 1-year price target for ONC is 6.8 CAD with a low forecast of 3.03 CAD and a high forecast of 9.45 CAD.